You are here

Home 🌿 Medical Cannabis News 🌿 Kamloops doctor part of study on medical marijuana for PTSD use 🌿

Kamloops doctor part of study on medical marijuana for PTSD use

Submitted by Marijuana News on Thu, 09/22/2016 - 08:45

Dr. Ian Mitchell is a Kamloops emergency room physician, with a keen interest in pot.

Specifically medicinal marijuana, and how it might be used as an anti anxiety medication and for people with post-traumatic stress disorder.

Dr. Mitchell is sharing what he knows as part of the Kamloops Adult Learners' Society programming for the fall.

To listen to the full interview, play below:

READ MORE: 
CBC
e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 
British Columbia
Canada

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


420 Intel is Your Source for Marijuana News

420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.

420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.

Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.

You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.